Moderna (MRNA) stock surged Thursday after the Covid vaccine-maker beat Wall Street's quarterly expectations, including turning around a surprise profit. ...

Investor's Business Daily 02/22/2024 04:10 PM ET

Hot Biotech Play Breaks Out Into By Range

A mix of choppy or nonexistent earnings alongside the promise of game-changing breakthroughs make biotech stocks a challenge for investors. ...

Investor's Business Daily 01/08/2024 02:34 PM ET

View All »

IBD Partners

No News Available.

STOCK/COMPANY DATA FOR MRNA

Stock Data

Today's Range
103.52 - 108.23

52-Week Range
62.55 - 142.79

Price % Chg. YTD
6.77%

Price % Chg. Last 4 Weeks
3.21%

50-Day Avg. Volume
3,822,400

Shares Outstanding
382.9 Mil

Float
321.6 Mil

IPO Date
12/07/2018

Investment Bank
Morgan Stanley

% Mgmt Owns
15.2%

PE Ratio
0

Dividend Yield
0

Alpha
-0.12

Beta
1.05

Company Fundamentals

EPS Due Date
5/2/2024

EPS % Chg (Last Qtr)
-85%

3 Year EPS Growth Rate
0%

EPS Est % Chg (Current Yr)
40%

Annual ROE
0%

Sales % Chg (Last Qtr)
-45%

3-Year Sales Growth Rate
60%

Debt %
4%

Market Cap
$40.7 B $41 Bil

Annual Pre -Tax Margin
-57.6%

Sector
medical

Industry Group
Medical-Biomed/Biotech

Industry Group Rank
22